Disclosed funding across 31 venture rounds, IPOs and private placements reported since Oct. 1. We also reported 15 acquisitions; those priced in dollars total $12.1B.
| Date | Company | Type | Amount | Lead investors / buyer | Sector |
|---|---|---|---|---|---|
| Nov. 17 | Marrow Therapeutics | Series B | $173M | OrbiMed, Scion Life Sciences, venBio | Biotech |
| Nov. 17 | ODAIA | Series C | $15M | Monograph Capital | Health AI |
| Nov. 17 | Isomorphic Labs | Series C | $5B | Greenoaks, Sequoia Capital | Biotech |
| Nov. 16 | Knit Health | Series A | $35M | NEA | Health AI |
| Nov. 16 | Remedy Robotics | Series B | $62M | DCVC | Medtech |
| Nov. 16 | Aytu BioPharma | Acquisition | $56M | Rosemont Pharmaceuticals | Pharma |
| Nov. 16 | Ollin Biosciences | Acquisition | $2.2B | Johnson & Johnson | Biotech |
| Nov. 16 | Galvanize Therapeutics | Series D | $130M | HealthQuest Capital | Medtech |
| Nov. 16 | Calytrix Bio | Acquisition | $1.5B | Eli Lilly and Company | Biotech |
| Nov. 13 | AgileMD | Acquisition | $100M | Wolters Kluwer Health | Health AI |
| Nov. 13 | InspireMD | Follow-on | $37.5M | Medtech | |
| Nov. 12 | Boone Health | Acquisition | $47M | Ardent Health | Healthcare Services |
| Nov. 12 | Windward Bio | IPO | $175M | Biotech | |
| Nov. 11 | XpertDox | Series A | $20M | Savant Growth | Health AI |
| Nov. 10 | Counsel Health | Acquisition | $625M | Oura | Health AI |
| Nov. 10 | Zus Health | Series B | $33M | Drive Capital | Digital Health |
| Nov. 10 | Charta Health | Series B | $55M | Insight Partners | Health AI |
| Nov. 10 | Nanopath | Series B | $25M | Norwest, SV Health Investors' MedTech Convergence Fund | Diagnostics |
| Nov. 9 | Unnatural Products | Acquisition | $550M | argenx | Biotech |
| Nov. 5 | T-Therapeutics | Series B | $133M | Advent Life Sciences, British Business Bank | Biotech |
| Nov. 2 | nPhase | Series D | $30M | Viking Global Investors | Health AI |
| Oct. 29 | Bambusa Therapeutics | IPO | $169M | Biotech | |
| Oct. 29 | Midstream Health | Series A | $20M | Valtruis | Health AI |
| Oct. 29 | StimCardio Medical | Series A | $30M | Metis MedTech | Medtech |
| Oct. 27 | Vera Health | Series A | $28.5M | Threshold Ventures | Health AI |
| Oct. 26 | Onrad | Acquisition | $350M | RadNet | Healthcare Services |
| Oct. 21 | Qiagen | Acquisition | €10.8B | EQT Private Equity | Diagnostics |
| Oct. 20 | Baba | Series A | $40M | FirstMark Capital | Digital Health |
| Oct. 19 | Silence Therapeutics | Acquisition | $1.3B | Merck KGaA, Darmstadt, Germany | Biotech |
| Oct. 16 | Ovation Healthcare | Acquisition | Undisclosed | Parkview Health | Healthcare Services |
| Oct. 16 | Estuary Biotherapeutics | Series A | $93M | RA Capital Management | Biotech |
| Oct. 15 | Sirona Medical | Series D | $40M | Avidity Partners | Health AI |
| Oct. 15 | BioReference Health (select assets) | Acquisition | $722M | Labcorp | Diagnostics |
| Oct. 14 | Kaigene | Private placement | $55M | Biotech | |
| Oct. 13 | Suki | Series E+ | $90M | Health AI | |
| Oct. 12 | Xodus Medical | Acquisition | $2.1B | Steris | Medtech |
| Oct. 8 | MMI (Medical Microinstruments) | Series D | $125M | BioStar Capital | Medtech |
| Oct. 8 | Pacira BioSciences | Acquisition | $1.65B | Viatris | Pharma |
| Oct. 7 | Healthleap | Series A | $38M | Hummingbird Ventures, Sequoia Capital, First Round Capital | Health AI |
| Oct. 7 | Matchpoint Therapeutics | Series B | $150M | Nextech Invest, Norwest | Biotech |
| Oct. 6 | General Medicine | Series B | $120M | Andreessen Horowitz | Digital Health |
| Oct. 6 | Vitalize | Series A | $31M | Oak HC/FT | Health AI |
| Oct. 5 | Virtual Incision | Private placement | $35.1M | Medtech | |
| Oct. 5 | Zenflow | Series D | $52M | Cook Medical | Medtech |
| Oct. 5 | SOFIE Biosciences | Acquisition | $945M | GE HealthCare | Diagnostics |
| Oct. 1 | Amani Therapeutics | Private placement | $35M | Biotech |
Every deal here was reported in a Charted story, and each row links to that story and its sources. Amounts are as disclosed by the company or in an SEC filing; undisclosed amounts count as zero in the totals, and we do not convert other currencies to dollars. Financings include venture rounds, IPOs, follow-ons, debt, and private placements disclosed on Form D. Acquisitions are listed but kept out of the financing total.
The day's deals, FDA decisions and policy moves, by the numbers. Free. Sign up now to get the first edition.